1. Home
  2. TENX vs LGO Comparison

TENX vs LGO Comparison

Compare TENX & LGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Tenax Therapeutics Inc.

TENX

Tenax Therapeutics Inc.

N/A

Current Price

$2.13

Market Cap

71.1M

Sector

Health Care

ML Signal

N/A

Logo Largo Inc.

LGO

Largo Inc.

N/A

Current Price

$0.73

Market Cap

62.8M

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
TENX
LGO
Founded
1967
1988
Country
United States
Canada
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
71.1M
62.8M
IPO Year
2001
2007

Fundamental Metrics

Financial Performance
Metric
TENX
LGO
Price
$2.13
$0.73
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
2
Target Price
$29.67
$3.25
AVG Volume (30 Days)
9.0M
559.9K
Earning Date
05-15-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$50.56
Revenue Next Year
N/A
$59.94
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.31
$0.55
52 Week High
$19.40
$2.70

Technical Indicators

Market Signals
Indicator
TENX
LGO
Relative Strength Index (RSI) 23.92 56.53
Support Level $1.31 $0.59
Resistance Level $14.15 $0.83
Average True Range (ATR) 0.20 0.06
MACD 0.17 0.01
Stochastic Oscillator 75.00 71.74

Price Performance

Historical Comparison
TENX
LGO

About TENX Tenax Therapeutics Inc.

Tenax Therapeutics Inc is a phase three, development-stage pharmaceutical company focused on identifying and developing therapeutics that address cardiovascular and pulmonary diseases with high unmet medical need, with an initial therapeutic focus on pulmonary hypertension. Its drug development pipeline comprises: Levosimendan, a novel, first-in-class K-ATP activator and calcium sensitizer developed for intravenous use in hospitalized patients with acutely decompensated heart failure; and Imatinib, as a potential therapy for pulmonary arterial hypertension. The company is currently conducting clinical trials only for levosimendan as its prioritized product candidate to evaluate its potential to help patients with pulmonary hypertension.

About LGO Largo Inc.

Largo Inc is committed to the production and supply of high-quality vanadium products. The company is also focused on the advancement of renewable energy storage solutions through Largo Clean Energy and its vanadium redox flow battery technology. The Company is engaged in the mining, exploration, and development of mineral properties, predominantly in Brazil, through which it produces and supplies vanadium products VPURE Flake, VPURE+ Flake, and VPURE+ Powder. The company has operating segments: sales & trading, mine properties, which generates key revenue, corporate, exploration and evaluation properties, Clean Energy, and Largo Physical Vanadium.

Share on Social Networks: